Isolated thrombocytopenia associated with hydroxyurea/deferiprone (L1) therapy in a sickle beta thalassemia patient.
Sheikh-Taha
Marwan
M
Lebanese American University; Byblos, Lebano.
Koussa
Suzane
S
Taher
Ali
A
D000328:Adult; D000986:Antisickling Agents / Q000009:adverse effects*; D000077543:Deferiprone; D004359:Drug Therapy, Combination; D006801:Humans; D006918:Hydroxyurea / Q000009:adverse effects*; D007502:Iron Chelating Agents / Q000009:adverse effects*; D008297:Male; D010976:Platelet Count; D011728:Pyridones / Q000009:adverse effects*; D013921:Thrombocytopenia / Q000139:chemically induced*; D017086:beta-Thalassemia / Q000188:drug therapy*
D000986:Antisickling Agents; D007502:Iron Chelating Agents; D011728:Pyridones; D000077543:Deferiprone; D006918:Hydroxyurea